Merit Medical Net Income Over Time
| MMSI Stock | USD 79.63 0.26 0.33% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Merit Medical Performance and Merit Medical Correlation. Is there potential for Health Care Equipment & Supplies market expansion? Will Merit introduce new products? Factors like these will boost the valuation of Merit Medical. Expected growth trajectory for Merit significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.04) | Earnings Share 1.92 | Revenue Per Share | Quarterly Revenue Growth 0.13 | Return On Assets |
Investors evaluate Merit Medical Systems using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Merit Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Merit Medical's market price to deviate significantly from intrinsic value.
Understanding that Merit Medical's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Merit Medical represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Merit Medical's market price signifies the transaction level at which participants voluntarily complete trades.
Cross Equities Net Income Analysis
Compare Merit Medical Systems and related stocks such as Teleflex Incorporated, Bausch Lomb Corp, and Stevanato Group SpA Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TFX | 13.3 M | 323.3 M | (190.1 M) | 150.9 M | 187.7 M | 244.9 M | 237.4 M | 152.5 M | 200.8 M | 461.5 M | 335.3 M | 485.4 M | 363.1 M | 356.3 M | 69.7 M | 80.1 M | 151.6 M |
| BLCO | 710 M | 710 M | 710 M | 710 M | 710 M | 710 M | 710 M | 710 M | 710 M | 298 M | (18 M) | 182 M | 6 M | (260 M) | (317 M) | (285.3 M) | (271 M) |
| STVN | 39.2 M | 39.2 M | 39.2 M | 39.2 M | 39.2 M | 39.2 M | 39.2 M | 39.2 M | 39.2 M | 39.2 M | 78.5 M | 134.3 M | 142.8 M | 145.6 M | 117.8 M | 135.4 M | 120.7 M |
| KRYS | (1.1 M) | (1.1 M) | (1.1 M) | (1.1 M) | (1.1 M) | (1.1 M) | (1.1 M) | (7.9 M) | (10.9 M) | (19.1 M) | (32.2 M) | (69.6 M) | (140 M) | 10.9 M | 89.2 M | 102.5 M | 107.7 M |
| TGTX | (3.6 M) | (853.1 K) | (18.1 M) | (20.5 M) | (55.8 M) | (62.9 M) | (78.3 M) | (118.5 M) | (173.5 M) | (172.9 M) | (279.4 M) | (348.1 M) | (223.8 M) | 12.7 M | 23.4 M | 21 M | 22.1 M |
| GKOS | (19.3 M) | (19.3 M) | (19.3 M) | (12.6 M) | (12.1 M) | (37.2 M) | 4.5 M | (92 K) | (13 M) | 15.4 M | (120.3 M) | (49.6 M) | (99.2 M) | (134.7 M) | (146.4 M) | (131.7 M) | (125.1 M) |
| ALKS | (40.1 M) | 25 M | 25 M | 17.6 M | (30.1 M) | (227.2 M) | (208.4 M) | (157.9 M) | (139.3 M) | (196.6 M) | (110.9 M) | (48.2 M) | (158.3 M) | 355.8 M | 367.1 M | 422.1 M | 443.2 M |
| PTCT | 30.9 M | 30.9 M | (26.2 M) | (51.6 M) | (93.8 M) | (170.4 M) | (142.1 M) | (79 M) | (128.1 M) | (251.6 M) | (438.2 M) | (523.9 M) | (559 M) | (626.6 M) | (363.3 M) | (327 M) | (343.3 M) |
| TMDX | (17.6 M) | (24.1 M) | (24.1 M) | (24.1 M) | (24.1 M) | (24.1 M) | (24.1 M) | (20.8 M) | (23.8 M) | (33.5 M) | (28.7 M) | (44.2 M) | (36.2 M) | (25 M) | 35.5 M | 40.8 M | 42.8 M |
| BRKR | (888 K) | 92.3 M | 77.5 M | 80.1 M | 56.7 M | 101.6 M | 153.6 M | 78.6 M | 179.7 M | 197.2 M | 157.8 M | 277.1 M | 296.6 M | 427.2 M | 113.1 M | 130.1 M | 104.3 M |
Merit Medical Systems and related stocks such as Teleflex Incorporated, Bausch Lomb Corp, and Stevanato Group SpA Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Merit Medical Systems financial statement analysis. It represents the amount of money remaining after all of Merit Medical Systems operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Merit Medical Systems | MMSI |
| Classification | Drugs |
| Business Address | 1600 West Merit |
| Exchange | NASDAQ Exchange |
USD 79.63
Check out Merit Medical Performance and Merit Medical Correlation. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Merit Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.